Values as of: 2024-12-26
ETF | Health |
Last Closing
USD 90.32Change
+0.72 (+0.80)%Market Cap
USD 0.21BVolume
0.01MAnalyst Target
N/AVerdict
Verdict
In seeking to track the performance of the S&P Health Care Equipment Select Industry Index (the index), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the health care equipment segment of the S&P Total Market Index (S&P TMI).
Company Website : http://www.spdrs.com
Currency: USD
Country : USA
| Symbol | Name | Price(Change) | Market Cap |
|---|---|---|---|
| XLV | Health Care Select Sector SPDR.. |
+0.28 (+0.20%) |
USD 36.67B |
| FHLC | Fidelity® MSCI Health Care In.. |
+0.19 (+0.29%) |
USD 2.62B |
| FXH | First Trust Health Care AlphaD.. |
+0.42 (+0.40%) |
USD 1.09B |
| IDNA | iShares Genomics Immunology an.. |
+0.13 (+0.57%) |
USD 0.12B |
| SBIO | ALPS Medical Breakthroughs ETF |
+0.64 (+1.90%) |
USD 0.11B |
| XHS | SPDR® S&P Health Care Service.. |
+0.68 (+0.75%) |
USD 0.07B |
| HTEC | Robo Global® Healthcare Techn.. |
+0.16 (+0.55%) |
USD 0.05B |
| BBP | Virtus LifeSci Biotech Product.. |
+0.69 (+1.13%) |
USD 0.02B |
| BBC | Virtus LifeSci Biotech Clinica.. |
+0.42 (+1.71%) |
USD 0.01B |
| IHE | iShares U.S. Pharmaceuticals E.. |
+0.26 (+0.39%) |
N/A |
| Symbol | Name | Weight | Mer | Price(Change) | Market Cap |
|---|---|---|---|---|---|
| INAV | 0.00 % | 0.00 % |
N/A |
N/A |
| Market Performance vs. Industry/Classification (Health) | Market Performance vs. Exchange | ||||||
| Value | Sector Median | Percentile Rank | Grade | Market Median | Percentile Rank | Grade | |
| YTD | |||||||
| Capital Gain | 7.19% | 86% | B+ | 56% | F | ||
| Dividend Return | 0.04% | 6% | D- | N/A | F | ||
| Total Return | 7.23% | 81% | B- | 47% | F | ||
| Trailing 12 Months | |||||||
| Capital Gain | 5.72% | 81% | B- | 54% | F | ||
| Dividend Return | 0.04% | 6% | D- | N/A | F | ||
| Total Return | 5.76% | 76% | C+ | 44% | F | ||
| Trailing 5 Years | |||||||
| Capital Gain | 5.30% | 29% | F | 52% | F | ||
| Dividend Return | 0.11% | 5% | F | N/A | F | ||
| Total Return | 5.42% | 29% | F | 32% | F | ||
| Average Annual (5 Year Horizon) | |||||||
| Capital Gain | -0.04% | 24% | F | 31% | F | ||
| Dividend Return | -0.03% | 24% | F | 20% | F | ||
| Total Return | 0.01% | 5% | F | 1% | F | ||
| Risk Return Profile | |||||||
| Volatility (Standard Deviation) | 26.52% | 33% | F | 41% | F | ||
| Risk Adjusted Return | -0.11% | 24% | F | 20% | F | ||
| Market Capitalization | 0.21B | 70% | C- | 37% | F | ||
| Target Price Action | Rating Action | Analyst | Rating | Price | Date |
|---|
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
There is nothing we particularly like
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
The company has under performed its peers on annual average total returns in the past 5 years.
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
